GGrantIndex
Sort

78,016 grants matching breast cancer

Translating Unique Learning for Incontinence Prevention: The TULIP Project

$612,913
Carolyn M Sampselle · University Of Michigan At Ann Arbor · R01 · FY2010 · NR

HSET as a racial disparity biomarker for TNBC patients

$612,894
Ritu Aneja · Georgia State University · R01 · FY2019 · CA

Population-Based Evaluation of Artificial Intelligence for Mammography Prior to Widespread Clinical Translation

$612,889
Christoph I Lee · University Of Washington · R01 · FY2023 · CA

Translational Pathology Core

$612,876
William Dean Wallace · University Of Southern California · P30 · FY2025 · CA

Cardiovascular Impact of Near-complete Estrogen Deprivation for Breast Cancer

$612,704
Alexandra Thomas · Wake Forest University Health Sciences · R01 · FY2023 · HL

Predicting Long-Term Chemotherapy-Related Cognitive Impairment

$612,633
Shelli R Kesler · University Of Texas At Austin · R01 · FY2020 · CA

Shared Genomic Segment Analysis and Tumor Subtyping in High-Risk BrCa Pedigrees

$612,611
Nicola J Camp · University Of Utah · R01 · FY2012 · CA

Novel dietary interventions for reducing obesity-associated breast cancer

$612,513
Paul S Maclean · University Of Colorado Denver · R01 · FY2024 · CA

Medical Care Burden of Cancer: System and Data Issues

$612,493
Mark Christopher Hornbrook · Kaiser Foundation Research Institute · R01 · FY2007 · CA

Multicenter trial of decision support for breast cancer chemoprevention

$612,470
Katherine D Crew · Columbia University Health Sciences · R01 · FY2022 · CA

Breast Cancer Integrative Oncology: Prospective Matched Controlled Outcomes Study

$612,433
Leanna J Standish · Bastyr University · R01 · FY2012 · AT

Development of a Multi-Panel Multiplex Immunofluorescence Breast Cancer Immunophenotyping Assay

$612,419
David Schwartz · Cell Idx, Inc. · R44 · FY2015 · CA

RNA circuits for cell state determination in mammalian cells in vitro and in vivo

$612,414
Ron Weiss · Massachusetts Institute Of Technology · R01 · FY2017 · CA

Breast and Other Carcinoma Clinical Trials Using Immunotherapies

$612,359
Margaret Gatti-Mays · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Cancer Immunotherapy Clinical Trials

$612,359
Julius Strauss · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Tyrosine phosphorylation of p27Kip1 as a biomarker to identify Cdk4/6 inhibitor response

$612,351
Janice L Brissette · Suny Downstate Medical Center · R01 · FY2023 · CA

Single cell characterization of the biomaterial immune and stromal response

$612,340
Jennifer Hartt Elisseeff · Johns Hopkins University · R01 · FY2022 · EB

Single cell characterization of the biomaterial immune and stromal response

$612,340
Jennifer Hartt Elisseeff · Johns Hopkins University · R01 · FY2023 · EB

Epigenetics and Psychoneurologic Symptoms in Women with Breast Cancer

$612,303
Debra E Lyon · Virginia Commonwealth University · R01 · FY2010 · NR

Experimental-Computational Synthesis of Altered Immune Signaling in Breast Cancer

$612,300
Peter Poon-Hang Lee · Beckman Research Institute/City Of Hope · U01 · FY2022 · CA

COOPERATIVE FAMILY REGISTRY FOR BREAST CANCER STUDIES

$612,245
University Of Utah · U01 · FY2001 · CA

Engineered Invasive Human Breast Tumors with Integrated Capillaries and Lymphatics

$612,218
Joe Y Tien · Boston University (Charles River Campus) · U01 · FY2021 · CA

Advanced PET/CT Imaging for Improving Clinical Trials

$612,217
Paul E Kinahan · University Of Washington · U01 · FY2019 · CA

Next Generation Rat Models of ER+ Breast Cancer

$612,175
Yi Li · Baylor College Of Medicine · R01 · FY2022 · CA

Aerobic Capacity, Depression, & Inflammatory Responsivity in Cancer Survivors

$612,145
Janice K Kiecolt-Glaser · Ohio State University · R01 · FY2019 · CA